Highly active antiretroviral therapy (HAART) and prolonged survival of a patient with an HIV-related Burkitt lymphoma, despite an intracardiac relapse

被引：6
作者：
Brinkman, K
Delnoy, PP
de Pauw, B
机构：
[1] Univ Nijmegen Hosp, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Cardiol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen Hosp, Dept Haematol, NL-6500 HB Nijmegen, Netherlands
来源：
INTERNATIONAL JOURNAL OF STD & AIDS | 1998年 / 9卷 / 12期
关键词：
HIV; Burkitt lymphoma; cardiac manifestation; survival;
D O I：
10.1258/0956462981921404
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：773 / 775
页数：3
相关论文
共 50 条
[31]   HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone [J].
Girard, T ;
Luquet-Besson, I ;
Baran-Marszak, F ;
Raphaël, M ;
Boué, F .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (01) :70-72
[32]   Highly active antiretroviral therapy-related effects on morphological connectivity in HIV [J].
Wang, Yiwen ;
Wu, Guangyao ;
Wen, Zhi ;
Lei, Hao ;
Lin, Fuchun .
AIDS, 2024, 38 (02) :207-215
[33]   Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy [J].
Lambotte, O ;
Taoufik, Y ;
de Goër, MG ;
Wallon, C ;
Goujard, C ;
Delfraissy, JF .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (02) :114-119
[34]   Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children [J].
Esposito, S ;
Porta, A ;
Bojanin, J ;
Gualtieri, L ;
Cesati, L ;
Vismara, E ;
Principi, N .
EYE, 2006, 20 (05) :595-597
[35]   Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis [J].
Velasco, Maria ;
Castilla, Virgilio ;
Sanz, Jose ;
Gaspar, Gabriel ;
Condes, Emilia ;
Barros, Carlos ;
Cervero, Miguel ;
Torres, Rafael ;
Guijarro, Carlos .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (02) :148-152
[36]   Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients [J].
de Olalla, PG ;
Knobel, H ;
Carmona, A ;
Guelar, A ;
López-Colomés, JL ;
Caylà, JA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (01) :105-110
[37]   Characterization of the HIV-1 specific humoral immune response during highly active antiretroviral therapy (HAART) [J].
Morris, MK ;
Katzenstein, DA ;
Israelski, D ;
Zolopa, A ;
Hendry, RM ;
Hanson, CV .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 28 (05) :405-415
[38]   HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre [J].
Kiely, B. ;
O'Flaherty, J. ;
Surah, S. ;
Kieran, J. ;
O'Donnell, D. ;
Bergin, C. ;
Mulcahy, F. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (05) :332-336
[39]   Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children [J].
S Esposito ;
A Porta ;
J Bojanin ;
L Gualtieri ;
L Cesati ;
E Vismara ;
N Principi .
Eye, 2006, 20 :595-597
[40]   Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy [J].
Thirlwell, C ;
Sarker, D ;
Stebbing, J ;
Bower, M .
CLINICAL LYMPHOMA, 2003, 4 (02) :86-92
12345